IRIS
LONGO, MIRIAM
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 349
EU - Europa 282
AS - Asia 20
OC - Oceania 1
Totale 652
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 349
IE - Irlanda 181
IT - Italia 45
DE - Germania 33
CN - Cina 12
FI - Finlandia 10
BE - Belgio 4
CH - Svizzera 3
IN - India 3
IR - Iran 3
CZ - Repubblica Ceca 2
HK - Hong Kong 2
NL - Olanda 2
SE - Svezia 2
AU - Australia 1
Totale 652
Salva come PNG Salva come JPEG
Città #
Dublin 180
Chandler 108
New York 25
Ashburn 19
Bremen 19
Cambridge 16
Princeton 16
Roxbury 16
Beijing 11
Marigliano 7
Boardman 6
Lappeenranta 6
Cagliari 5
Naples 5
Brussels 4
Helsinki 4
Turin 4
Boydton 3
Calitri 3
Lugano 3
Munich 3
Napoli 3
North Charleston 3
Pune 3
Forlì 2
Fossano 2
Los Angeles 2
San Nicola la Strada 2
Amsterdam 1
Borås 1
Brdo 1
Brno 1
Caivano 1
Capua 1
Cardito 1
Clonee 1
Grottaminarda 1
Hanover 1
Lamezia Terme 1
Langweer 1
Nuremberg 1
Sassari 1
Seattle 1
Stockholm 1
Sydney 1
Totale 497
Salva come PNG Salva come JPEG
Nome #
Change in circulating levels of endothelial progenitor cells and sexual function in women with type 1 diabetes 58
Applications for social security benefits related to diabetes in the working age in Italy between 2009 and 2019: a nationwide retrospective cohort study 42
Simplification of complex insulin therapy: a story of dogma and therapeutic resignation 39
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs 34
Exploring the performance of ultrasound risk stratification systems in thyroid nodules of pediatric patients 34
Sodium-glucose co-transporter-2 inhibitors for the prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis 33
Renal and metabolic effects of SGLT-2i and DPP-4i according to basal estimated glomerular filtration rate: Analysis from GIOIA, an observational prospective study 33
Mediterranean diet in type 2 diabetes: An updated overview of pharmacological activities of cardiometabolic and reproductive outcomes 33
Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues 33
Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression 32
When amputation is not the end of the challenge: A successful therapy for osteomyelitis and soft tissue infection in a patient with type 1 diabetes 32
SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs 30
GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off 30
The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs 30
Hypothalamic-Pituitary Autoimmunity and Related Impairment of Hormone Secretions in Chronic Fatigue Syndrome 26
Feasibility of simplification from a basal-bolus insulin regimen to a fixed-ratio formulation of basal insulin plus a glp-1ra or to basal insulin plus an SGLT2 inhibitor: BEYOND, a randomized, pragmatic trial 24
Neuroimmunoendocrinology of SARS-CoV 2 Infection 24
European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events 23
Varicocele: An Endocrinological Perspective 22
Reply to the letter to the editor by Mungmunpuntipantip et al 20
Repeat thyroid FNAC: Inter-observer agreement among high- and low-volume centers in Naples metropolitan area and correlation with the EU-TIRADS 18
Assessment of Neuroendocrine Changes and Hypothalamo-Pituitary Autoimmunity in Patients with COVID-19 15
Circulating levels of endothelial progenitor cells are associated with better cognitive function in older adults with glucagon-like peptide 1 receptor agonist-treated type 2 diabetes 11
Signs of a Glucose and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes 9
Telemedicine for type 2 diabetes during COVID-19 pandemic: experience from a tertiary diabetes center 3
Glucose control during breakthrough SARS-CoV-2 infections in vaccinated patients with type 1 diabetes 2
Two years with GIOIA 'Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes': A prospective, multicentre, quasi-experimental study on sodium-glucose cotransporter 2 and dipeptidyl peptidase-4 inhibitors in diabetes clinical practice 2
BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes 2
Liraglutide for Lower Limb Perfusion in People With Type 2 Diabetes and Peripheral Artery Disease: The STARDUST Randomized Clinical Trial 1
Totale 695
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.434
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.434
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202289 0 0 0 0 0 0 4 3 11 17 3 51
2022/2023416 44 6 9 25 71 26 0 25 188 6 6 10
2023/2024190 24 7 10 23 51 45 14 2 4 9 1 0
Totale 695